REVOLUTION MEDICINES
Live / Registered — Registered (as of 03 Sept 2024)
What this means for you
Registered since 03 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98298243
- Registration number
- 7495362
- Mark type
- Design + words
- Filed
- 04 Dec 2023
- Published for opposition
- 18 Jun 2024
- Registered
- 03 Sept 2024
- Attorney of record
- Melissa A. Nowak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development; drug discovery services; providing information about medical and scientific research
- Class 044 — Medical, beauty and agricultural services: Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disorders
Owner
- Revolution Medicines, Inc., Redwood City, CA, US
- Revolution Medicines, Inc., Redwood City, CA, US
- Revolution Medicines, Inc., Redwood City, CA, US
Prior registrations
Prosecution history
- 03 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jun 2024 — PUBLISHED FOR OPPOSITION
- 29 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 May 2024 — EXAMINER'S AMENDMENT ENTERED
- 15 May 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 May 2024 — EXAMINERS AMENDMENT E-MAILED
- 15 May 2024 — EXAMINERS AMENDMENT -WRITTEN
- 15 May 2024 — EXAMINER'S AMENDMENT ENTERED
- 15 May 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 May 2024 — EXAMINERS AMENDMENT E-MAILED
- 15 May 2024 — EXAMINERS AMENDMENT -WRITTEN
- 11 May 2024 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED